生物科技遇到人工智能。碳基人类x硅基聊天机器人。《一线生机》为您跟踪最前沿、最热门的生物科技话题，捕捉生物科技前沿的投资机会。
Podcast Overview
生物科技遇到人工智能。碳基人类x硅基聊天机器人。《一线生机》为您跟踪最前沿、最热门的生物科技话题，捕捉生物科技前沿的投资机会。
Language
🇨🇳
Publishing Since
7/13/2024
1 verified contact email on file for 一线生机
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
November 2, 2024
一线生机15:美国大选与药企变局
<p>谁掌舵生物科技？贺锦丽vs特朗普，不仅是一场总统之争，更是生物医药行业的分水岭。药价谈判、监管政策、产业链重构……每一步政策变化都牵动着全球医药巨头的神经。这场大选，会让中国创新药企迎来突破良机，还是面临出海阻力？CRO/CDMO会遭遇供应链重构的阵痛，还是获得产业升级的契机？且听本期《一线生机》为您解读大选背后的行业生存术。</p>
October 19, 2024
一线生机14: 辉瑞跌倒！阿吉奥斯能否一飞冲天？
<p>辉瑞重磅药物全球退市，带来血液病治疗领域地震！本期一线生机为您深度解析这一事件对行业的冲击。聚焦阿吉奥斯(Agios)生物科技公司，其明星药物米他匹伐能否借机崛起？从镰状细胞病到地中海贫血，米他匹伐展现出惊人潜力。但基因疗法的崛起又将如何改变市场格局？本期节目还将探讨阿吉奥斯的产品管线多元化策略，以及近17亿美元的现金储备能否支撑其雄心勃勃的研发计划。一线生机，带您站在生物科技最前沿，洞察投资先机！ </p>
October 9, 2024
一线生机13:救命药物还是致命隐患？辉瑞药物退市风波
<p>68亿美元的豪赌,一场惊天逆转！辉瑞公司斥巨资收购的明星药物,竟因致命副作用紧急退市。本期《一线生机》带您深入剖析这场震撼医药界的风波,揭秘药物研发的暗礁与陷阱。从欧洲药监局的警报到全球退市,我们将追踪这场灾难性并购的始末,探讨其对生物科技投资的深远影响。一场关乎生命的豪赌,如何演变成灾难?且听本期节目为您揭晓!</p>
12 total episodes available
Deep-dive analytics for 一线生机
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is 一线生机?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.